Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Current Pharmaceutical Design, 1381-6128

Journal

  1. 2018
  2. Published

    Chronic Inflammatory Diseases and Atherosclerotic Cardiovascular Disease: Innocent Bystanders or Partners in Crime?

    Hansen, P. R., 2018, In : Current Pharmaceutical Design. 24, 3, p. 281-290 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2017
  4. Published

    Management of antiepileptic treatment after epilepsy surgery - practices and problems

    Rubboli, G., Sabers, A., Uldall, P. & Malmgren, K., 2017, In : Current Pharmaceutical Design. 23, 37, p. 5749-5759

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The role of antiplatelet therapy in primary prevention. A review

    Østergaard, L. K. M., Fosbøl, E. L. & Roe, M. T., 2017, In : Current Pharmaceutical Design. 23, 9, p. 1294-1306

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer

    Oellgaard, J., Winther, S. A., Hansen, T. S., Rossing, P. & von Scholten, B. J., 2017, In : Current Pharmaceutical Design. 23, 25, p. 3699-3712 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2016
  8. Published

    Hyperpolarized (13)C MR Angiography

    Lipsø, K. W., Magnusson, P. & Ardenkjaer-Larsen, J. H., 2016, In : Current Pharmaceutical Design. 22, 1, p. 90-95 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Old, New and Hidden Causes of Perioperative Hypersensitivity

    Garvey, L. H., 2016, In : Current Pharmaceutical Design. 22, 45, p. 6814-6824 11 p.

    Research output: Contribution to journalReviewResearchpeer-review

  10. Published
  11. 2015
  12. Published

    Genetic aspects of lone atrial fibrillation: what do we know?

    Andreasen, L., Nielsen, J. B. & Olesen, M. S., 2015, In : Current Pharmaceutical Design. 21, 5, p. 667-78 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2014
  14. Published

    Hyperpolarized Metabolic MR in the Study of Cardiac Function and Disease

    Lauritzen, M. H., Sogaard, L. V., Madsen, P. L. & Ardenkjaer-Larsen, J. H., 2014, In : Current Pharmaceutical Design. 20, 39, p. 6162-70 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Intervention Efficacy in Trials Targeting Cannabis Use Disorders in Patients with Comorbid Psychosis

    Hjorthoj, C. R., Baker, A., Fohlmann, A. & Nordentoft, M., 2014, In : Current Pharmaceutical Design. p. 2205-11 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2012
  17. Published

    Non-analgesic effects of opioids: the cognitive effects of opioids in chronic pain of malignant and non-malignant origin. An update

    Højsted, J., Kurita, G. P., Kendall, S., Lundorff, L., de Mattos Pimenta, C. A. & Sjøgren, P., 2012, In : Current Pharmaceutical Design. 18, 37, p. 6116-22

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Risk of bleeding related to antithrombotic treatment in cardiovascular disease

    Sørensen, R., Olesen, J. B., Charlot, M. & Gislason, G. H., 2012, In : Current Pharmaceutical Design. 18, 33, p. 5362-78 17 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. 2010
  20. Published

    Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology

    Thomsen, M. S., Hansen, H. H., Timmerman, D. B. & Mikkelsen, J. D., 1 Jan 2010, In : Current Pharmaceutical Design. 16, 3, p. 323-43 21 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. 2004
  22. The involvement of growth hormone (GH), insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in diabetic kidney disease

    Flyvbjerg, A., Khatir, D. S., Jensen, L. J. N., Dagnaes-Hansen, F., Gronbaek, H. & Rasch, R., 2004, In : Current Pharmaceutical Design. 10, 27, p. 3385-94 10 p.

    Research output: Contribution to journalReviewResearchpeer-review

ID: 94318